Drug
S 337395
S 337395: highest development phase Phase 2, developed by Shionogi. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| S-337395 NCT07214571 | Phase 2 | Respiratory Syncytial Virus Infections |
| S-337395 NCT06270511 | Phase 1 | Healthy Volunteers |
Latest
Follow S 337395 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.